Skip to content
ppharmaranks
Menu
Class IIOngoing

Chlorthalidone Tablets recall

FDA recall D-0461-2025 · initiated May 9, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 18, 2025How we research

AvKARE recalled Chlorthalidone Tablets in May 2025 — an FDA Class II recall (D-0461-2025) because Failed Dissolution Specifications.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Failed Dissolution Specifications

Wrong strength, or it did not keep

The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # 47947, Exp 05/31/2026

Quantity recalled: 962 cartons

Details

Product
Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-167-15
Recalling company
AvKARE
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide USA
Initiated
May 9, 2025
FDA report date
Jun 18, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Chlorthalidone Tablets recalled?
AvKARE recalled Chlorthalidone Tablets in May 2025 — an FDA Class II recall (D-0461-2025) because Failed Dissolution Specifications. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Chlorthalidone Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0461-2025 was: Failed Dissolution Specifications
Is a recalled Chlorthalidone Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Chlorthalidone Tablets are affected?
Distributed: Nationwide USA. The recall covers these lots — Lot # 47947, Exp 05/31/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0461-2025.

Source: openFDA Drug Enforcement record D-0461-2025

← All drug recalls